SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-18-013266
Filing Date
2018-01-18
Accepted
2018-01-18 15:28:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 d488080d424b3.htm 424B3 5871
  Complete submission text file 0001193125-18-013266.txt   6844
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 424B3 | Act: 33 | File No.: 333-220755 | Film No.: 18533906
SIC: 2834 Pharmaceutical Preparations